Company / Current Assets
Amphstar Pharmaceuticals, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$636.0M
FY2025
5-year range
$318.1M / $636.0M
FY2021-FY2025
Trend
+19.1%
vs FY2024
Sector context
#94 of 213
Health Care
What the data says
At $636M, Amphstar Pharmaceuticals, Inc.'s current assets ranks #94 of 213 in the Health Care sector. Current Assets has increased for 9 consecutive years, from $184M in FY2016 to $636M in FY2025.
Based on SEC 10-K filings.
$636M in FY2025 with a 5-year CAGR of +17.9%.
Improved from $490M to $636M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +18.9%
- 5-Year CAGR
- +17.9%
- 10-Year CAGR
- -
Sector benchmark
#94 of 213 in Health CareTop 44% of 213This company $636.0M Sector average $2.5B
▼
-74.8% below sector average
Key checks
Key Insights
- Amphstar Pharmaceuticals, Inc.'s current assets has grown for 9 consecutive years.
- 5-year CAGR of +17.9%, indicating consistent growth.
- In FY2025, current assets increased 19.1% year-over-year.
- Ranks #94 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $636.0M | +19.1% |
| FY2024 | $534.1M | +9.1% |
| FY2023 | $489.6M | +29.4% |
| FY2022 | $378.3M | +18.9% |
| FY2021 | $318.1M | +13.7% |
| FY2020 | $279.7M | +9.6% |
| FY2019 | $255.2M | +15.8% |
| FY2018 | $220.3M | +17.3% |
| FY2017 | $187.8M | +2.0% |
| FY2016 | $184.1M | +4.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026